Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6528
    +0.0027 (+0.42%)
     
  • OIL

    83.24
    +0.43 (+0.52%)
     
  • GOLD

    2,337.60
    -0.80 (-0.03%)
     
  • Bitcoin AUD

    98,082.41
    -4,140.19 (-4.05%)
     
  • CMC Crypto 200

    1,365.21
    -17.37 (-1.26%)
     
  • AUD/EUR

    0.6084
    +0.0013 (+0.22%)
     
  • AUD/NZD

    1.0947
    +0.0005 (+0.05%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,094.42
    +54.04 (+0.67%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,023.02
    -65.68 (-0.36%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why BioCryst Pharmaceuticals Stock Is Falling Today

Why BioCryst Pharmaceuticals Stock Is Falling Today

BioCryst Pharmaceuticals (NASDAQ: BCRX) stock is dropping sharply on Thursday after the biotech company reported disappointing fourth-quarter financial results. BioCryst's shares were down by 8.4% as of 1:53 p.m. EST. BioCryst's total revenue for the fourth quarter ending Dec. 31 was roughly $4 million, down from the $39.7 million in revenue recorded during the year-ago period.